{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T01:52:14Z","timestamp":1722217934013},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jdiacomp.2011.06.001","type":"journal-article","created":{"date-parts":[[2011,8,6]],"date-time":"2011-08-06T23:34:13Z","timestamp":1312673653000},"page":"377-381","source":"Crossref","is-referenced-by-count":6,"title":["Systemic resistin is increased in type 2 diabetic patients treated with loop diuretics"],"prefix":"10.1016","volume":"25","author":[{"given":"Sabrina","family":"Bauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Neumeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Wanninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Bala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Sch\u00e4ffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0005","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2005.05.004","article-title":"The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis","volume":"184","author":"Aristoteli","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/sj.ki.5000089","article-title":"Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance","volume":"69","author":"Axelsson","year":"2006","journal-title":"Kidney International"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0015","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1053\/j.ajkd.2006.08.022","article-title":"Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD","volume":"48","author":"Axelsson","year":"2006","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.atherosclerosis.2005.02.014","article-title":"The potential role of resistin in atherogenesis","volume":"182","author":"Burnett","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI37672","article-title":"Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure","volume":"120","author":"D'Apolito","year":"2010","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","article-title":"Inflammation and insulin resistance","volume":"582","author":"de Luca","year":"2008","journal-title":"FEBS Letters"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0083-6729(06)74018-3","article-title":"Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells","volume":"74","author":"Fain","year":"2006","journal-title":"Vitamins and Hormones"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0045","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1210\/jc.2005-0437","article-title":"Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance","volume":"90","author":"Gerber","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.diabet.2010.05.003","article-title":"Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients","volume":"36","author":"Gharibeh","year":"2010","journal-title":"Diabetes & Metabolism"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diabres.2006.10.007","article-title":"Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory","volume":"77","author":"Giulietti","year":"2007","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0060","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1210\/jc.2003-031410","article-title":"Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects","volume":"89","author":"Heilbronn","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0065","first-page":"485","article-title":"Resistin: a pathogenic factor or a biomarker of metabolic disorders and inflammation?","volume":"63","author":"Karbowska","year":"2009","journal-title":"Postepy Higieny I Medycyny Doswiadczalnej (Online)"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbrc.2003.07.003","article-title":"Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro","volume":"309","author":"Kaser","year":"2003","journal-title":"Biochemical and Biophysical Research Communication"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0029-1243638","article-title":"Visfatin\/PBEF\/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans","volume":"42","author":"Laudes","year":"2010","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0080","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2003-030519","article-title":"Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects","volume":"88","author":"Lee","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.mol.0000217899.59820.9a","article-title":"Resistin","volume":"17","author":"McTernan","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1373\/clinchem.2010.154724","article-title":"Serum soluble CD163 predicts risk of type 2 diabetes in the general population","volume":"57","author":"Moller","year":"2011","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1530\/eje.1.02338","article-title":"Plasma resistin levels correlate with determinants of the metabolic syndrome","volume":"156","author":"Norata","year":"2007","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0100","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","article-title":"Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators","volume":"300","author":"Patel","year":"2003","journal-title":"Biochemical and Biophysical Research Communication"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0105","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1172\/JCI37273","article-title":"Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice","volume":"119","author":"Qatanani","year":"2009","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0110","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1055\/s-2004-826015","article-title":"Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus","volume":"36","author":"Schaffler","year":"2004","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ncpgasthep0186","article-title":"Mechanisms of disease: adipocytokines and visceral adipose tissue \u2014 emerging role in nonalcoholic fatty liver disease","volume":"2","author":"Schaffler","year":"2005","journal-title":"Nature Clinical Practice Gastroenterology & Hepatology"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0120","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.bbrc.2007.07.106","article-title":"Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release","volume":"361","author":"Schober","year":"2007","journal-title":"Biochemical and Biophysical Research Communication"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/eje.0.1490331","article-title":"Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance","volume":"149","author":"Silha","year":"2003","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0130","doi-asserted-by":"crossref","unstructured":"Silha, J. V., & Murphy, L. J. (2004). Serum resistin (FIZZ3) protein is increased in obese humans. Journal of Clinical Endocrinology and Metabolism, 89, 1977; author reply 1977\u20131978.","DOI":"10.1210\/jc.2003-031988"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0135","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2362.2009.02170.x","article-title":"Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity","volume":"39","author":"Sporrer","year":"2009","journal-title":"European Journal of Clinical Investegation"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jim.2008.05.008","article-title":"Highly efficient and low-cost method to isolate human blood monocytes with high purity","volume":"337","author":"Stogbauer","year":"2008","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0150","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/HYPERTENSIONAHA.107.103077","article-title":"Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes","volume":"51","author":"Takata","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0155","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1253\/circj.71.460","article-title":"Serum resistin is associated with high risk in patients with congestive heart failure \u2014 a novel link between metabolic signals and heart failure","volume":"71","author":"Takeishi","year":"2007","journal-title":"Circulation Journal"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0160","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-2007-990288","article-title":"Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women","volume":"39","author":"Tsiotra","year":"2007","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0165","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/jc.2009-1619","article-title":"Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes","volume":"95","author":"Weigert","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0170","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2265.2009.03664.x","article-title":"Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes","volume":"72","author":"Weigert","year":"2010","journal-title":"Clinical Endocrinology (Oxf)"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0175","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0180","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.metabol.2009.09.011","article-title":"Splanchnic concentrations and postprandial release of visceral adipokines","volume":"59","author":"Wiest","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0185","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1210\/jc.2003-031121","article-title":"Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus","volume":"89","author":"Youn","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2011.06.001_bb0190","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1081-1206(10)62870-0","article-title":"Immunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cells","volume":"83","author":"Yuengsrigul","year":"1999","journal-title":"Annals of Allergy Asthma & Immunology"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872711000857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872711000857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T21:16:23Z","timestamp":1560460583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872711000857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1056872711000857"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2011.06.001","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}